SPRO icon

Spero Therapeutics

89 hedge funds and large institutions have $370M invested in Spero Therapeutics in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 34 increasing their positions, 23 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

14% more funds holding

Funds holding: 7889 (+11)

5.53% more ownership

Funds ownership: 64.67%70.19% (+5.5%)

26% less call options, than puts

Call options by funds: $1.5M | Put options by funds: $2.04M

Holders
89
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.5M
Puts
$2.04M
Net Calls
Net Calls Change

Top Buyers

1 +$17.4M
2 +$12.7M
3 +$5.15M
4
Morgan Stanley
Morgan Stanley
New York
+$4.81M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$3.91M

Top Sellers

1 -$11M
2 -$6.87M
3 -$4.31M
4
AIC
AWM Investment Company
New York
-$2.44M
5
AG
Artal Group
Luxembourg
-$1.94M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$259K
52
$248K
53
$233K
54
$210K
55
$202K
56
$194K
57
$183K
58
$174K
59
$171K
60
$166K
61
$130K
62
$128K
63
$99K
64
$95K
65
$73.6K
66
$61K
67
$58K
68
$51K
69
$43K
70
$41K
71
$39K
72
$38K
73
$37K
74
$33K
75
$32K